DOCSLIB.ORG

International Pelviperineology Congress Theme for 2016 - Chronic Pelvic Pain Registration Now Open Tel Aviv-Jaffa, Israel

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
International Pelviperineology Congress Theme for 2016 - Chronic Pelvic Pain Registration Now Open Tel Aviv-Jaffa, Israel 21-24/9/2016 ISPP Annual Scientific Meeting International Pelviperineology Conference International Pelviperineology Congress Theme for 2016 - Chronic pelvic pain Registration Now Open Tel Aviv-Jaffa, Israel www.pelviperineology.com [email protected] | congress organization: [email protected] ISPP Executive Committee President: Dr. Bernhard Liedl, Urologist, Munich, Germany Vice President: Professor Akin Sivaslioglu, Gynecologist, Istanbul, Turkey Secretary: Dr. Bruce Farnsworth, Urogynecologist, Sydney, Australia Treasurer: Dr. Darren Gold, Colorectal Surgeon, Sydney, Australia Education Officer: Professor Peter Petros, Gynecologist, Sydney, Australia Journal Editor: Professor Giuseppe Dodi, Colorectal Surgeon, Padova, Italy ISPP 2016 Co-chairs Dr. Naama Marcus Braun Prof. Menahem Neuman, MD Head of the Urogynecology Services, Ziv Medical Center, Safed, Israel In charge of Urogynecology, Ob-Gyn, Galilee MC, Nahariya, Israel Faculty of Medicine in the Galilee, Bar Ilan University, Israel Faculty of Medicine in the Galilee, Bar Ilan University, Safed, Israel www.pelviperineology.com [email protected] | congress organization: [email protected] Organizing committee Dr. Naama Marcus Braun Ada Rosen MD Head of the Urogynecology Services, Ziv Medical Center, Safed, Israel Chiarman Fellowship Comitte Faculty of Medicine in the Galilee, Bar Ilan University, Israel Department of surgery A proctology and pelvic floor clinic Wolfson Medical Center, Holon, Israel Prof. Menahem Neuman, MD Boris Friedman, MD In charge of Urogynecology, Ob-Gyn, Galilee MC, Nahariya, Israel Urology Department, Lady Davis Carmel medical center Faculty of Medicine in the Galilee, Bar Ilan University, Safed, Israel Rappaport faculty of medicine Technion Israel Institute of Technology, Haifa, Israel Bruce Farnsworth Adi Y. Weintraub Urogynecologist, Sydney Australia Urogynecology, Department of Obstetrics and Gynecology Soroka University Medical Center Faculty of Health Sciences, Ben-Gurion University of the Negev Beer Sheva, Israel Shimon Ginath Chairman of the Israeli Society of Urogynecology & Pelvic Floor Surgery Division of Urogynecology & Pelvic Floor Surgery, Department of Obstetrics & Gynecology, Edith Wolfson Medical Center, Holon Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel www.pelviperineology.com [email protected] | congress organization: [email protected] Scientific committee Prof. Peter Petros Dr. Benny Feiner University of NSW Professorial Surgery Unit Dept. Of obstetrics & gynecology St Vincent’s Hospital Hillel yaffe medical center Sydney, Astralia Technion facilty of medicine Adi Y. Weintraub Prof. Stuart Stanton Urogynecology, Department of Obstetrics and Gynecology President of the British Society of Urogynecology and past head Soroka University Medical Center of the Dept. of Urogynecology at St. George’s Hospital Faculty of Health Sciences, Ben-Gurion University of the Negev Beer Sheva, Israel Shimon Ginath Chairman of the Israeli Society of Urogynecology & Pelvic Floor Surgery Division of Urogynecology & Pelvic Floor Surgery, Department of Obstetrics & Gynecology, Edith Wolfson Medical Center, Holon www.pelviperineology.com [email protected] | congress organization: [email protected] Program Tuesday 20th September 18:00 Welcome reception for the ISPP 2016 registered attendees “Babay” oriental fish restaurant, on Jaffa’s sea side (Next to the congress venue) Wednesday 21st September 09:00-12:00 Workshops 1 The Integral Theory System - Peter Petros 2 Pelvic Floor Ultrasound - Giulio Santoro 3 Chronic Urogenital Pain (CUP), Diagnosis and Treatment - Marek Jantos & Sherie Johns 4 Treatments for Anal Incontinence and Refractory OAB - Ada Rosen 12:00-12:30 Lunch for Workshops attendees ISPP Annual conference 12:00-13:00 Registration 13:00-13:15 Welcome remarks -Bernhard Liedl, Eitan Lunenfeld, Naama Marcus-Braun and Menahem Neuman 13:15-14:15 1st Abstract Session Chairs: Ron Sagiv, Shimon Ginat, Peter Petros www.pelviperineology.com [email protected] | congress organization: [email protected] Program st Wednesday 21 September Plenary Session 2: Posterior Compartment ISPP Annual conference Chairs: Alon Pikarsky, Ada Rosen, Antonio Longo Plenary Session 1: Chronic Pelvic Pain 16:00-16:15 Obstructed defecation – current diagnosis and Chairs: Jacob Bornstein, Inbar Ben Shachar, management - yehuda kariv Moti Goldenberg Colorectal surgeon Tel Aviv, Israel 14:15-14:25 Chronic urogenital pain -Marek Jantos & Sherie Johns 16:15-16:30 Treatment of rectal prolapse - Noam Shussman Psychologist and RN, Australia Colorectal surgeon, Jerusalem, Israel 14:25-14:35 Chronic pelvic pain - new concepts and directions - 16:30-16:40 Comparison between STARR and posterior Peter Petros colporrhaphy in the treatment of obstructed Urogynecologist, Sydney, Australia defecation syndrome - Doraid Matani 14:35-14:45 Analog syndromes: Allen Masters and Posterior Fornix Medical student, Tel Aviv, Israel Syndromes - Naama Marcus 16:40-17:10 POPS and STARR operations - Antonio Longo, Urogynecologist, Safed, Israel Colorectal surgeon, Austria 14:45-14:55 Pain related to vaginal prolapse - Bernhard Liedl 17:10-17:25 Surgical treatment of fecal incontinence - Urogynecologist, Germany Alon Pikarsky,Colorectal surgeon, Jerusalem Israel 14:55-15:05 Management of chronic pelvic pain - Erkut Attar 17:25-17:40 Sacral and tibial stimulation as a treatment for Gynecologist, Turkey incontinence - Ada Rosen 15:05-15:15 Evaluation of patient with CPP - Ran Keidar Colorectal surgeon, Holon, Israel Gynecologist, Holon, Israel 17:40-17:50 Discussion 15:15-15:25 New definition of vulvar pain - Jacob Bornstein 17:50-19:00 2ND Abstract Session Gynecologist, Nahariya, Israel Chairs: Stuart Stanton, Yuki Sekiguchi, 15:25-15:40 Discussion Burghard Abendstein 15:40-16:00 Coffee break 20:00 Faculty dinner – upon invitation www.pelviperineology.com [email protected] | congress organization: [email protected] Program Thursday 22nd September 09:30-09:40 Future treatments for IC - Shachar Aharony Plenary Session 3: Urology –OAB Urologist, Israel Chairs: David Waltregny, Jacob Golomb, Revital Arbel 09:40-09:55 International Society Study Interstitial Cystitis - 08:30-08:40 Refractory OAB - Gil Meyer Mauro Cervigni Urologist, Haifa, Israel Urogynecologist, Italy 08:40-08:50 Elderly OAB/DHIC - Ilan Gruenwald 09:55-10:05 Native tissue ligament repair against anticholinergics Urologist, Haifa, Israel for urge incontinence in patients with minimal vaginal 08:50-09:00 Botox - Yoram Abrahmov prolapse - Anastacia Zaitseva Urogynecologist, Haifa, Israel Urologist, St. Petersburg, Russia 09:00-09:10 Urge incontinence: anticholinergics drugs vs. native repair 10:05-10:15 Application of the integral theory to post-vesico-vaginal Dmitry Shkarupa fistula repair incontinence - Peter Petros Urogynecologist, St. Petersburg, Russia Urogynecologist, Sydney, Australia 09:10-09:20 Discussion 10:15-10:20 Discussion 10:20-10:30 Greetings: Shimon Ginath, Alexander Greenstein Plenary Session 4: Female Urology and Hagit Tulchinsky Chairs: Yoram Abramov, Gabriel Gillon, 10:30-10:40 Honoring Prof. Stuart Stanton Asnat Groutz Chair: Ronen Gold 09:20-09:30 IC definition and diagnosis - Boris Friedman Moderator: Haim Krissi Urologist, Haifa, Israel 10:40-11:10 Coffee break www.pelviperineology.com [email protected] | congress organization: [email protected] Program Thursday 22nd September Plenary Session 6: Urinary Incontinence Plenary Session 5: Urinary Incontinence Chairs: Zvi Klein, Lior Lowenstein, David Yohay Chairs: Saygili Esra, Benny Feiner, Robert Molner 12:15-12:25 TESA vs. vaginal repair - Burghard Abendstein 11:10-11:20 Male sling - Dr. Ran Katz Urogynecologist, Austria Urologist, Safed, Israel 12:25-12:35 Medical vs. surgical treatment of urge urinary 11:20-11:30 Liege experience with male sling - David Waltregny incontinence - Sebastian Ludwig Urologist, Liege, Belgium Urogynecologist, Germany 11:30-11:40 Artificial urinary sphincter - Michael Gross, Israel 12:35-12:45 CESA or VASA for urinary incontinence in women - 11:40-11:50 Long term effect of primary bulkamid - Kurt Lobodasch Walfram Jäger Urogynecologist, Chemnitz, Germany Urogynecologist, Germany 11:50-12:00 Midurethral sling surgery for USI recurrence - 12:45-12:55 The influence of bariatric surgery on LUTS - Ates Karateke Asnat Groutz Gynecologist, Istanbul, Turkey Urogynecologist, Tel Aviv, Israel 12:00-12:15 Discussion 12:55-13:05 Photo-thermal laser treatment of pelvic floor dysfunction Adolf Lukanovič Gynecologist, Ljubljana, Slovenia 13:05-13:15 Discussion 13:15-14:00 Lunch & AGM (Annual General Meeting) www.pelviperineology.com [email protected] | congress organization: [email protected] Program Thursday 22nd September 15:45-15:55 Pregnancy after POP and SUI repair: What do we 14:00-15:00 3rd Abstract Session know? - Benny Feiner Chairs: Adolf Lukanovič, Michel Cosson, Urogynecologist, Hadera, Israel Viki Kapustian 15:55-16:05 Combined technology of pelvic floor reconstruction based on PIVS - Nikita Kubin Plenary Session 7: POP Surgery Urologiest St. Petersburg, Russia Chairs: Haim Krissi, Peter von Theobald, Ginadi Bitman 16:05-16:15 Discussion 15:00-15:15 Meshes textile engineering implant materials: 16:15-16:45 Coffee break Facts and figures - Oliver Gramalla Quality, Safety and Design for Textile Implants SERAG-WIESSNER, Germany 15:15-15:25 Fixation of various pelvic implants - Michael Halaska Urogynecologist, Prague, Czech
Load more

Recommended publications
  • State of the //ART// of the State
    State of the //ART// of the State A Political Economy of Assisted Reproduction in Palestine/Israel Sigrid Vertommen Dissertation submitted in fulfillment of the requirements for the degree of Doctor in Political and Social Sciences, option Political Sciences. Middle East and North Africa Research Group - Department of Conflict and Development Studies, Ghent University March 2017 Supervisor: Prof. dr. Sami Zemni Cover design by Aïlien Reyns TABLE OF CONTENTS Summary ................................................................................................................................................................................ v Samenvatting ..................................................................................................................................................................... vi List of Abbreviations ...................................................................................................................................................... vii List of Figures .................................................................................................................................................................... ix Acknowledgements ......................................................................................................................................................... xi Introduction ....................................................................................................................................................... 1 State of the ART ............................................................................................................................................................
    [Show full text]
  • Scientific Program
    The 63th Annual Conference of the Israel Heart Society in association with the Israel Society of Cardiothoracic Surgery April 12-13 • 2016 • Tel Aviv, Israel SCIENTIFIC PROGRAM Paragon Israel (Dan Knassim) Paragon Tel/Fax:03-5767730/7 Israel (Dan Knassim) a Paragon Group Company [email protected] TUESDAY, APRIL 12, 2016 08:30-10:00 Interventional Cardiology I Hall A Chairs: Ariel Finkelstein, Ran Kornowski, Israel 08:30 Effect of Diameter of Drug-Eluting Stents Versus Bare-Metal Stents on Late Outcomes: a propensity score-matched analysis Amos Levi1,2, Tamir Bental1,2, Hana Veknin Assa1,2, Gabriel Greenberg1,2, Eli Lev1,2, Ran Kornowski1,2, Abid Assali1,2 1Cardiology, Rabin Medical Center, Israel 2Sackler Faculty of Medicine, Tel Aviv University, Israel 08:41 Percutaneous Valve-in-Valve Implantation for the Treatment of Aortic, Mitral and Tricuspid Structural Bioprosthetic Valve Degeneration Uri Landes1, Abid Assali1, Ram Sharoni1,2, Hanna Vaknin-Assa1, Katia Orvin1, Amos Levi1, Yaron Shapira1, Shmuel Schwartzenberg1, Ashraf Hamdan1, Tamir Bental1, Alexander Sagie1, Ran Kornowski1 1Department of Cardiology, Rabin Medical Center, Tel Aviv, Israel 2Department of Cardiac Surgery, Rabin Medical Center, Tel Aviv, Israel 08:52 Temporal Trends in Transcatheter Aortic Valve Implantation in Israel 2008-2014: Patient Characteristics, Procedural Issues and Clinical Outcome Uri Landes1, Alon Barsheshet1, Abid Assali1, Hanna Vaknin-Assa1, Israel Barbash3, Victor Guetta3, Amit Segev3, Ariel Finkelstein2, Amir Halkin2, Jeremy Ben-Shoshan2,
    [Show full text]
  • Antibiotic Treatment for Invasive Listeriosis and Patient
    Antibiotic treatment for invasive listeriosis and patient outcome: a retrospective cohort study Yaakov Dickstein1, Yonatan Oster2, Orit Shimon3, Lior Nesher4, Dafna Yahav3,5, Yonit Wiener-Well6, Regev Cohen7,8, Ronen Ben-Ami3,9, Miriam Weinberger3,10, Galia Rahav3,11, Yasmin Maor3,12, Michal Chowers3,13, Ran Nir-Paz2, Mical Paul1,8 1 Institute of Infectious Diseases, Rambam Health Care Campus, Haifa, Israel 2 Department of Clinical Microbiology and Infectious Diseases, Hadassah-Hebrew University Medical Center, Jerusalem, Israel 3 Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel 4 Infectious Disease Institute, Soroka Medical Center, Ben-Gurion University of the Negev, Beer Sheba, Israel 5 Infectious Diseases Unit, Rabin Medical Center, Beilinson hospital, Petah-Tikva, Israel 6 Infectious Disease Unit, Shaare Zedek Medical Center, Jerusalem, Israel 7 Infectious Diseases Unit, Sanz Medical Center–Laniado Hospital , Netanya, Israel 8 The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel 9 Infectious Diseases Unit, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel 10 Infectious Diseases Unit, Assaf Harofeh Medical Center, Zerifin, Israel 11 Infectious Disease Unit, Sheba Medical Center, Ramat Gan, Israel 12 Infectious Disease Unit, Wolfson Medical Center, Holon, Israel 13 Infectious Diseases Unit, Meir Medical Center, Kfar Saba, Israel Cumulative survival by treatment group Background: Current treatment started within 48 hours of culture recommendations for treatment of results and continued for a minimum duration invasive listeriosis suggest ampicillin- of 7 days. Patients who died within 48 hours of based therapy with the addition of an the index culture were excluded. The primary aminoglycoside. However, several outcome was 30-day all-cause mortality.
    [Show full text]
  • December 2013 Prof. Reuven Zimlichman Chief of Medicine and Hypertension Institute, the E
    R. Zimlichman M.D. December 2013 Prof. Reuven Zimlichman Chief of Medicine and Hypertension Institute, The E. Wolfson Medical Center P.O.B. 5, Holon 58100 Israel and Head of Cardiovascular Research Institute, Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel Phone: 972-3-5028614, FAX: 972-3- 5032693 e-mail: [email protected] Prof. R. Zimlichman, M.D. is presently Chief Departments of Medicine and Head of Hypertension Institute at the E. Wolfson Medical Center, Israel, he is the Director of The Brunner Cardiovascular Research Institute, Tel-Aviv University. He is also the immediate past Vice Dean and Head of School of Continuing Education, Sackler Faculty of Medicine, Tel Aviv University. Prof. Zimlichman did his fellowship in Hypertension at the Hypertension Endocrine Branch, NIH, NHLBI in Bethesda, Maryland, USA (1983 to 1986). During the following years he returned for prolonged periods of research in the Hypertension Endocrine Branch and in the Clinical Neurocardiology section. Prof. Zimlichman joined the Faculty of Health Sciences at Ben Gurion University and Soroka Medical Center in Beer Sheva, Israel. He was nominated as Chief of Clinical and Experimental Hypertension in the Faculty of Medicine and in the Medical Center. Prof. Zimlichman was nominated as Chief of Medicine in the Sheba Medical Center, Tel Hashomer, in 1989 and was nominated as Associate Professor in Medicine at the Tel Aviv University, Sackler School of Medicine in 1994. In 1991 Prof Zimlichman was nominated as Chief of Department of Medicine in the Wolfson Medical Center, and in 1998 was nominated as Chief Departments of Medicine at the Wolfson Medical Center.
    [Show full text]
  • The 49Th Conference of the Israeli Society of Nephrology and Hypertension April 25Th - 27Th, 2013 | Dan Caesarea Hotel Scienti C Programme
    The 49th Conference of the Israeli Society of Nephrology and Hypertension April 25th - 27th, 2013 | Dan Caesarea Hotel Scientic Programme Organizing Committee Dr. Eliezer Golan, President, ISNH. Meir Medical Center, Kfar Saba Dr. Talia Weinstein, Vice-President, ISNH. Sourasky Medical Center, Tel Aviv Scientic Committee Dr. Suheir Assady, Chairperson, Rambam Health Care Campus, Haifa Dr. Talia Weinstein, Sourasky Medical Center, Tel Aviv Dr. Sydney Benchetrit, Meir Medical Center, Kfar Saba The 49th Conference of the Israeli Society of Nephrology and Hypertension April 25th - 27th, 2013 | Dan Caesarea Hotel Scientic Programme Day 1 - Thursday, April 25th, 2013 12:30 - 13:30 Reception, Exhibition & Lunch 13:30 - 13:50 Session 1 13:30 - 13:40 Greetings & Opening Remarks Dr. Suheir Assady, Dr. Eliezer Golan 13:40 - 13:50 ISNH RENAL REGISTRY (IRR) - Annual Report Dr. Eliezer Golan 13:50 - 15:15 Session 2 Chairs: Dr. Gabriel Mordochovic, Dr. David Tovbin 13:50 - 14:50 Free Communications- Dialysis and Hypertension 13:50 PERCUTANEOUS RENAL REVASCULARIZATION: A LONG TERM FOLLOW- UP OF 155 PROCEDURES Daniel Kushnir1, Jeri Marcusohn1, Alon Antebi1, Rima Sukhotnik1, and Victor Frajewicki1. 1 Department of Nephrology and Hypertension, Carmel Medical Center, Haifa. 14:00 PAIN MANAGEMENT IN PATIENTS WITH ADVANCED CHRONIC KIDNEY DISEASE: RESULTS OF ONE CENTER EXPERIENCE Isabelle Haggiag1,2, Yael Einbinder1, Jacques Bernheim 1,2 and Sydney Benchetrit1,2. 1 Department of Nephrology and Hypertension, Meir Medical Center, Kfar Saba; 2Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv. 14:10 RISK MANAGEMENT AND QUALITY CONTROL PARAMETERS IN ONE HEMODIALYSIS CENTER: A CLINICAL AND PATIENT CARE ATTITUDE Ze'ev Katzir1, Olga Shmain-Naidanov2, Relu Cernas1, Zvi Barnea1, Alexander Biro1, and Mona Boaz3.
    [Show full text]
  • Neuro-Ophthalmology in Israel
    Worldwide Neuro-Opthalmology Section Editor: Kathleen B. Digre, MD Neuro-Ophthalmology in Israel Ruth Huna-Baron, MD, Eitan Zvi Rath, MD FIG. 1. Pioneers of neuro-ophthalmology in Israel. euro-ophthalmology was introduced in Israel during challenge of the rapid development of new and expensive N the late 1970s by Riri Manor, Yochanan Goldhammer, diagnostic and therapeutic modalities, a committee of the and Isaac Gutman (Fig. 1). They trained with from William Ministry of Health each year announces new technologies Hoyt, Lawton Smith, and Myles Behrens, respectively. These and therapies to be included in basic health coverage. There pioneers trained many local ophthalmologists, neurologists, are 18 magnetic resonance imaging devices in Israel and 5 and neuro-ophthalmologists in Israel, and their efforts resulted interventional neurovascular units, and most medical in 21 neuro-ophthalmologists currently serving a population centers in the country have a neuro-ophthalmology service of 8 million. Many Israeli neuro-ophthalmologists did fellow- (Table 1). Much like in the United States, referrals come ships in the United States with a variety of other mentors, from neurologists, ophthalmologists, neurosurgeons inter- including Ronald Burde, Joel Glaser and Norman Schatz, ventional neuroradiologists, and endocrinologists. Mark Kupersmith, Byron Lam, Neil Miller, Barry Scarf, In 1997, the Israeli Neuro-Ophthalmology Society was and Jonathan Trobe. founded by Ririo Manor as a subspecialty section of the In Israel, each citizen is entitled to health care services Israeli Ophthalmology Society. Two annual meetings are under the National Health Insurance Law. To meet the organized by the society, of which one hosts a leading TABLE 1.
    [Show full text]
  • Israeli Cardio-Oncology Society Virtual Meeting Preliminary Program
    January 13-14, 2021 | Virtual Conference TOWARDS A COMPREHENSIVE CARDIAC-CANCER CARE Take this unique opportunity to join the ISCO 2021 conference and to effectively reach hundreds of cardiologists, oncologists and hemato-oncologists. Join us and present your research and technology to this influential and knowledgeable audience, and to have full access to all networking benefits. Conference secretariat - Dirigo Events & Conferences 3 Menorat Hamaor st. Tel-Aviv, Israel For more information, please contact: Tel: 03-7775485 | Email: [email protected] Yael Ziv Project Manager – Industry Liaison, Dirigo | Mobile: +972-54-5599821 | Email: [email protected] ISRAELI CARDIO-ONCOLOGY SOCIETY VIRTUAL MEETING PRELIMINARY PROGRAM Platinum Sponsorship Gold Sponsorship Silver Sponsorship January 13, 2021 15:45-16:00 Opening Session 15:45-15:47 Zaza Iakobishvili, Founder and Chair of the Meeting, Cardiology 15:47-15:49 Dan Gilon, Chair of the Meeting, Cardiology 15:49-15:51 David Sarid, Chair of the Meeting, Oncology 15:51-15:53 Martin Ellis, Chair of the Meeting, Hematology 15:53-15:55 Alex Lyon, ESC Cardio-Oncology Council 15:55-15:57 Bonnie Ky, JACC Cardio-Oncology 16:00-17:00 Plenary Session Chairs: Giorgio Minnotti, Faculty of Medicine and Surgery, Campus Bio-Medico University of Rome, Italy Alexander Battler, Chairman, Advisory Council on Cardiovascular Disease Management and Prevention, Ministry of Health, Israel 16:00-16:20 How to establish Cardio-Oncology collaboration Susan F. Dent, Associate Director of Breast Cancer Clinical Research, Co-Director Duke Cardio-Oncology Program, Durham, NC, USA 16:20-16:40 Guidelines in Cardio-Oncology: Gaps and Opportunities José Luis Zamorano, University Hospital Ramon Y Cajal, Madrid, Spain 16:40-17:00 Panel discussion: Future of Cardio-Oncology Richard H.
    [Show full text]
  • Curriculum Vitae Deeb Zabeeda, Md
    CURRICULUM VITAE DEEB ZABEEDA, M.D. I.D. No.054465919; Passport No. 6980824 PLACE OF WORK: The E. Wolfson Medical Center Anesthesia Department Holon, Israel Tel: (03) 502-8211 Fax: (03) 503-6408 HOME ADDRESS: Hanna Senesh Street 25 Lod, Israel 71203 Tel: (08) 925-4812 BIRTH DATE / PLACE: October 28, 1958 / Lod, Israel FAMILY: Married, 3 children LANGUAGES: Arabic, Hebrew, German, English EDUCATION: 1970-1974 Intermediate School, Lod, Israel 1974-1976 High School, Kfar Tira, Israel 1978-1985 University of Leipzig, School of Medicine, Germany LICENSURE: May 1985 Diploma of Medicine Sep 1985 Medical License - Germany No. 126/85 Nov 1986 Medical License - Israel No. 018591 Nov 1994 Specialty in Anesthesia - Israel No. 14187 CLINICAL TRAINING AND EXPERIENCE Sep 1984-May 1985 Clinical training for German Medical Licensure Oct 1985-Oct 1986 Clinical training for Israeli Medical Licensure Feb 1987-Mar 1990 Anesthesia Residency, E. Wolfson Medical Center Holon, Israel. Apr 1990-Sep 1990 Internal Medicine Rotation, E. Wolfson Medical Center, Holon, Israel. Oct 1990-Mar 1991 Intensive Care Rotation, E. Wolfson Medical Center, Holon, Israel. Apr 1991-Sep 1991 Basic Science Rotation, Infection and Intensive Care Units, E. Wolfson Medical Center, Holon, Israel. Oct 1991-Apr 1993 Cardiac Surgery Anesthesia Rotation, E. Wolfson Medical Center, Holon Israel. May 1993-Sep 1993 Anesthesia for Neurosurgery, Ichilov Medical Center, Tel Aviv, Israel. Jan 1996-Apr 1996 Anesthesia for Pediatric Cardiac Surgery, Schneider Children’s Hospital, Petah Tiqva, Israel. May 1997-July1997 Pediatric Anesthesia, Sick Children’s Hospital, Toronto, Canada. 1994-present Senior Staff Anesthesiologist, E. Wolfson Medical Center, Holon, Israel.
    [Show full text]
  • 1 CURRICULUM VITAE Anat E. Leibler June, 2014 1. PERSONAL DETAILS Address: 7 Moshe Sneh Street, Ra'anana 43728 ISRAEL Telep
    Anat E. Leibler June 2014 CURRICULUM VITAE Anat E. Leibler June, 2014 1. PERSONAL DETAILS Address: 7 Moshe Sneh Street, Ra’anana 43728 ISRAEL Telephone: 0544-207067 E-mail: [email protected] 2. HIGHER EDUCATION 1988 B.Ed, Beit Berl College, Kfar Sava, Israel 1998 MA, (Magna Cum Laude) Tel Aviv University, Department of Sociology and Anthropology Thesis: Statistics as Social Architecture: On the Construction of the Central Bureau of Statistics as an A-political Institution (Hebrew) Advisors: Daniel Breslau, Tel Aviv University, and Michael Shalev, the Hebrew University of Jerusalem 1999-2000 Doctoral studies at Tel Aviv University. 2000-2004 PhD student, University of California at San Diego, Department of Sociology and the Science Studies Program 2004 PhD Candidate, University of California at San Diego, Department of Sociology and the Science Studies Program 2008 PhD, UCSD, in Science Studies and Sociology, University of California, San Diego. December. Co-Chairs: Theodore Porter, (UCLA) and Nancy Cartwright, (UCSD and LSE). Committee Members: Chandra Mukerji, Andrew Lakoff, Richard Biernacki and Steve Epstein (UCSD) 2007-2008 Postdoctoral Fellow, Department of Political Science, Hebrew University of Jerusalem, Israel. (See #7, #13). 2011-2012 Post-Doctoral Fellow, Edelstein Center for the History and Philosophy of Science, Technology and Medicine. (See #2). 3. ACADEMIC APPOINTMENTS 2008- Teaching Fellow, Science, Technology and Society Studies Program, Bar-Ilan University. 2008-2009 Teaching Fellow, History, Philosophy and Sociology of Science Program, The Hebrew University of Jerusalem. 2012 -2013 Teaching Fellow, History Department, The Hebrew University of Jerusalem. 1 Anat E. Leibler June 2014 2013- Teaching Fellow, The Department of Politics and Government, Ben- Gurion University.
    [Show full text]
  • The 7Th Fetal Neurosonography Masterclass
    THE 7TH FETAL NEUROSONOGRAPHY MASTERCLASS UNDER THE AUSPICES OF: ISRAELI SOCIETY OF ULTRASOUND IN OBSTETRICS & GYNECOLOGY May 31- June2, 2020 Kfar HaMaccabiah Hotel, Ramat Gan, Israel Course Directors Prof. Gustavo Malinger Prof. Mauricio Herrera For demonstrations of interest and enquires contact: [email protected] Welcome letter Dear Friends: I have been looking forward to see you in Israel and to have the opportunity to pass on the knowledge we had accumulated in the field of Fetal Neurosonography during the last 30 years. For more than two decades I worked at the Edith Wolfson Medical Center, where an exceptionally talented group of people had the opportunity to meet and work together to create in 1994 what was probably the first multidisciplinary group in the field of Fetal Neurology. The initial group was composed of Prof. Tally Lerman-Sagie (Pediatric Neurology), Dr. Dorit Lev (Genetics) and myself. Dr. Liat Ben Sira (Pediatric Radiology-MRI) joined from Tel Aviv Medical Center and Dr. Deborah Kidron (Pathology) from Sapir Medical Center. During the years the Fetal Neurology Clinic at Wolfson became the leader in the field of fetal CNS care and research in Israel with more than 500 referrals/year and more than 50 publications and a book. Eight years ago I moved from Wolfson to Tel-Aviv Sourasky Medical Center; the hospital has over 12000 deliveries per year and with the OB-GYN US Unit team we have an increasingly number of suspected CNS pathologies for evaluation and have diagnosed, in this relatively short period, more than 1200 CNS pathological cases. We will count with the participation of other Israeli renowned Fetal Medicine specialists including Dr.
    [Show full text]
  • Second Ethics Committee Approval Granted by Leading Israeli Hospital for the Phase II Clinical Trial on COVID-19 Patients
    28 April 2020 Second Ethics Committee Approval Granted by Leading Israeli ASX Code: MXC Hospital for the Phase II Clinical Trial on COVID-19 Patients MGC Pharmaceuticals Ltd (ASX: MXC, ‘MGC’ or ‘the Company’), a European based ‘Seed to Medicine’ bio- pharma company specialising in the production and development of phytocannabinoid-derived medicines, is pleased to announce it has been granted a second Human Research Ethics Committee (‘Ethics Committee’) approval from the Hillel Yaffe Hospital in Israel for an additional site to conduct the Phase II placebo controlled clinical trial to evaluate the safety and efficacy of a natural anti-infective based formulation (‘ArtemiC’ or the ‘Product’) on patients diagnosed with COVID-19 (the ‘Trial’). This is a key milestone for the Company and the planned clinical trial on the Product on patients diagnosed with COVID-19, with the validation from a second leading medical hospital in Israel to run the Phase II trial. Hillel Yaffe Hospital is one of the major specialist hospitals in Israel operating since 1957, specialising in organ implants, trauma and general treatments, having served over 450,000 people. Highlights • ArtemiC is designed with the scientific aim to target viral infections with inflammatory complications, and is now to be evaluated on novel coronavirus 2019 (SARS-CoV-2) infected patients in a double-blind placebo controlled, Phase II clinical trial • MGC has received a second Ethics Committee approval from Hillel Yaffe Hospital in Israel, for the Phase II clinical trial to be undertaken
    [Show full text]
  • & Medical Directory
    Health & Medical Directory 2015/16 allergy • alternative medicine • cardiology dental • dermatology • endocrinology • internal gastroenterology • gynecology • ophthalmology orthopedic • otolaryngology • pediatrics pharmacy • plastic surgery • proctology psychotherapy • surgery • laboratories medical centers & hospitals The iQ Method - Custom Tailored Refractive Surgery The method that expends the possibilities of refractive surgery The optimal solution for reading glasses and multifocals The iQ method is our most advanced treatment. It is suitable for a greater number of people, including those who in the past were found to be unsuitable for refractive surgery. The procedure is very accurate and extremely safe. It allows for a quick and easy recovery,and for an tŝƚŚƚŚĞ immediate return to normal life. iQ method The iQ method is also the best and safest recovery is quick ĂůƚĞƌŶĂƟǀĞĨŽƌƚŚŽƐĞǁŚŽĚŽŶŽƚǁŝƐŚƚŽ and painless ƐƵīĞƌƚŚĞůŽŶŐĂŶĚƉĂŝŶĨƵůƌĞĐŽǀĞƌLJŝŶǀŽůǀĞĚ with immediate in methods such as LASEK, PRK or ASA. return to ƌ͘ƌŝĞůtĞŶĚĞƌ͕ normal life dŚĞŝYŵĞƚŚŽĚʹƚŚĞŽƉƟŵĂůƐŽůƵƟŽŶ medical manager at iClinic ĨŽƌƌĞĂĚŝŶŐŐůĂƐƐĞƐĂŶĚŵƵůƟĨŽĐĂůƐ Around the mid 40's, there is a gradual The iQ method The iQ method is suitable for many is the safe deterioration in near vision. Many who never needed glasses in the past, now who were found unsuitable for laser ĂůƚĞƌŶĂƟǀĞƚŽ procedures in the past painful recovery need reading glasses, and as the years ĂŌĞƌWZ< go by, they also depend on glasses dŚĞŝYŵĞƚŚŽĚĞdžƉĂŶĚƐƚŚĞƉŽƐƐŝďŝůŝƟĞƐŽĨ for distance or, alternatively, wear ƌĞĨƌĂĐƟǀĞƐƵƌŐĞƌLJ͘dŚŽƐĞǁŝƚŚŚŝŐŚŵLJŽƉŝĂ͕ multifocals. and even very high myopia, can go back to The iQ method Now at the iClinic, through the use of seeing clearly without glasses. With the iQ is the right way the iQ method, you may restore your method thin corneas can be treated with the to treat: eyesight to any distance to what it was same level of accuracy and safety as normal high myopia, when you were younger, all with a quick, corneas.
    [Show full text]